Many Opioid Prescribers View Patient Provider Agreements as Unhelpful in Minimizing Opioid Misuse
Most PPAs in prescribers’ practices focused on rules and consequences of noncompliance instead of on a shared treatment plan.
Most PPAs in prescribers’ practices focused on rules and consequences of noncompliance instead of on a shared treatment plan.
The authors propose evaluating which aspects of previous policy and practices for OUD should resume and which aspects of current policy and practice exemptions should continue.
The number of individuals filling buprenorphine prescriptions for OUD has plateaued but not decreased during the COVID-19 pandemic.
Walmart is being sued by the US Justice Department for its alleged role in the nation’s opioid crisis.
Researchers assessed whether patients with osteoarthritis and NSAID allergies have higher odds of developing opioid use disorder, and identified next steps to be considered for this patient population.
Adolescent sleep deficiency as an increased future risk for prescription opioid misuse was examined in a large nationally, representative database designed to track health behaviors and outcomes from adolescence to early adulthood.
Researchers evaluated opioid use disorder hospitalizations and associated healthcare utilization outcomes in patients with common musculoskeletal diseases.
State scope-of-practice laws impact the ability of nurse practitioners to prescribe medication-assisted treatment for patients with opioid use disorder.
Researchers developed a microsimulation model of the natural history of injection opioid use to assess long-term infective endocarditis mortality associated with injection opioid use in the United States.
Researchers convened to develop recommendations on management of sedation and analgesia in critically ill patients receiving naltrexone for opioid use disorder.